Power of Attorney for SEC Filings

This filing is an Exhibit 24, a Power of Attorney document for Sandeep Menon, Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC. The document, dated March 10, 2026, and signed by Sandeep Menon on April 7, 2026, appoints Alane P. Barnes and Sara A. Mykrantz as attorneys-in-fact. They are authorized to execute and submit necessary SEC filings, including Form ID and Section 16 Filings (Forms 3, 4, and 5), on behalf of Mr. Menon. This authorization covers obtaining EDGAR codes, managing the EDGAR account, and performing any actions deemed beneficial or legally required for compliance with the Securities Exchange Act of 1934 and SEC regulations regarding the company's securities. The power of attorney remains in effect until Mr. Menon is no longer required to make such filings, unless revoked earlier.